Get started
OPKO HEALTHOPKO HEALTHOPKO HEALTH

OPKO HEALTH

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

OPK chart


Full chart

OPK upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.84 B‬ ILS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.7 ILS
Net income (FY)
‪−685.75 M‬ ILS
Revenue (FY)
‪3.14 B‬ ILS
Shares float
‪309.23 M‬
Beta (1Y)
0.96

Employees


Employees (FY)
‪3.93 K‬
Change (1Y)
−266 −6.34%
Revenue / Employee (1Y)
‪797.79 K‬ ILS
Net income / Employee (1Y)
‪−174.49 K‬ ILS

About Opko Health, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Phillip Frost
Website
opko.com
Headquarters
Miami
Founded
1991
FIGI
BBG005579TC1
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OPK news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

OPK highest yielding bonds


OPK4795151
OPKO Health, Inc. 4.5% 15-FEB-2025
Yield to maturity
31.77%
Maturity date
Feb 15, 2025
OPK4048118
OPKO Health, Inc. 3.0% 01-FEB-2033
Yield to maturity
—
Maturity date
Feb 1, 2033
OPK5733212
OPKO Health, Inc. 3.75% 15-JAN-2029
Yield to maturity
—
Maturity date
Jan 15, 2029
OPK4020628
OPKO Health, Inc. 3.0% 01-FEB-2033
Yield to maturity
—
Maturity date
Feb 1, 2033

Explore more bonds 

Frequently Asked Questions


The current price of OPK is 566.6 ILA — it has decreased by −2.23% in the past 24 hours. Watch OPKO HEALTH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange OPKO HEALTH stocks are traded under the ticker OPK.
OPK stock has risen by 0.49% compared to the previous week, the month change is a −8.67% fall, over the last year OPKO HEALTH has showed a −0.77% decrease.
We've gathered analysts' opinions on OPKO HEALTH future price: according to them, OPK price has a max estimate of 3,209.00 ILA and a min estimate of 755.06 ILA. Watch OPK chart and read a more detailed OPKO HEALTH stock forecast: see what analysts think of OPKO HEALTH and suggest that you do with its stocks.
OPK reached its all-time high on Jun 4, 2015 with the price of 7,500.0 ILA, and its all-time low was 315.0 ILA and was reached on Mar 19, 2024. View more price dynamics on OPK chart.
See other stocks reaching their highest and lowest prices.
OPK stock is 1.24% volatile and has beta coefficient of 0.96. Track OPKO HEALTH stock price on the chart and check out the list of the most volatile stocks — is OPKO HEALTH there?
Today OPKO HEALTH has the market capitalization of ‪3.84 B‬, it has increased by 1.78% over the last week.
Yes, you can track OPKO HEALTH financials in yearly and quarterly reports right on TradingView.
OPKO HEALTH is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
OPK earnings for the last quarter are 0.11 ILA per share, whereas the estimation was −0.35 ILA resulting in a 132.14% surprise. The estimated earnings for the next quarter are −0.29 ILA per share. See more details about OPKO HEALTH earnings.
OPKO HEALTH revenue for the last quarter amounts to ‪647.81 M‬ ILA, despite the estimated figure of ‪677.38 M‬ ILA. In the next quarter, revenue is expected to reach ‪567.63 M‬ ILA.
OPK net income for the last quarter is ‪92.88 M‬ ILS, while the quarter before that showed ‪−38.94 M‬ ILS of net income which accounts for 338.50% change. Track more OPKO HEALTH financial stats to get the full picture.
No, OPK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has ‪3.93 K‬ employees. See our rating of the largest employees — is OPKO HEALTH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPKO HEALTH EBITDA is ‪−781.40 M‬ ILS, and current EBITDA margin is −6.11%. See more stats in OPKO HEALTH financial statements.
Like other stocks, OPK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPKO HEALTH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPKO HEALTH technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPKO HEALTH stock shows the neutral signal. See more of OPKO HEALTH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.